Live Blog

Uruguay vaccinates half of its population

Uruguay has now rolled out a total of 1.8 million coronavirus vaccines, meaning that 51 percent of the country’s population has received at least one dose. Only Chile has a better vaccination rate in Latin America. Uruguayan health authorities now plan to inoculate citizens between 12 and 18 years old this month. 

The national campaign relies on three vaccines: CoronaVac — recently approved by the World Health Organization —, Pfizer, and AstraZeneca’s Covishield. 

Despite the promising vaccination coverage, coronavirus infections are on the rise in Uruguay, with 90 percent of all 4,300-plus deaths tallied so far occurring in the past six months. By October 2020, the country had confirmed just 52 coronavirus deaths. Experts say the spread is fueled by new variants of the virus, but also by the government’s delay in imposing restrictions as case numbers began increasing.

Lucas Berti

Lucas Berti covers international affairs — specialized in Latin American politics and markets. He has been published by Opera Mundi, Revista VIP, and The Intercept Brasil, among others.

Recent Posts

Ayrton Senna, a true Brazilian hero

In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…

9 hours ago

OECD improves Brazil’s GDP growth forecast once again

Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…

11 hours ago

Brazil missing the target with its match-fixing drama

“This is f***ing corruption, it has to change,” protested an irate John Textor, owner of…

11 hours ago

Rio Grande do Sul declares state of calamity due to rains

Eduardo Leite, governor of the southern Brazilian state of Rio Grande do Sul, on Wednesday…

11 hours ago

Lula, Congress swap places in fiscal responsibility debate

Moody’s is the latest rating agency to improve its assessment of Brazil, bumping up the…

12 hours ago

The Brazilian Report shortlisted for four Digiday Media Awards

Other finalists include the Harvard Business Review, Fortune, Condé Nast, and the NFL

15 hours ago